Ethical Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Indore, Madhya Pradesh, India, established in 1978.
1978 Indore, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Ethical Drugs Private Limited

Ethical Drugs Private Limited, a struck off private limited company, was established on 13 September 1978 in Indore, Madhya Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232MP1978PTC001466. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

Its leadership includes Aditya Earnest John (Director), Deepak Rampal (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 2/5, Manoramaganj, Indore, M.P., Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP1978PTC001466

  • Registration Number

    001466

  • Incorporation Date

    13 September 1978

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 47 Year, 8 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Ethical Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Ethical Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ethical Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Aditya Earnest John Director 01 Apr 2004 Current
Deepak Rampal Director 15 Jan 1997 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ethical Drugs.

Enhance accessibility to Ethical Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ethical Drugs revenue growth over time
Ethical Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ethical Drugs?

Unlock access to Ethical Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ethical Drugs?

Unlock and access historical data on people associated with Ethical Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ethical Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ethical Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ethical Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ethical Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Ethical Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Gwalior. was completed.

  • Director Appointment

    Aditya Earnest John was appointed as a Director was appointed as a Director on 01 Apr 2004 & has been associated with this company since 22 years 2 months . was recorded as a recent event.

  • Director Appointment

    Deepak Rampal was appointed as a Director was appointed as a Director on 15 Jan 1997 & has been associated with this company since 29 years 4 months . was recorded as a recent event.

  • Company Incorporation

    The activity Ethical Drugs Private Limited was registered on 13 Sep 1978 with Roc Gwalior & aged 47 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ethical Drugs Private Limited?

The CIN of Ethical Drugs Private Limited is U24232MP1978PTC001466.

Where is Ethical Drugs Private Limited headquartered?

Ethical Drugs Private Limited is headquartered at 2/5, Manoramaganj, Indore, M.P., Indore, Madhya Pradesh, 452001.

When was Ethical Drugs Private Limited incorporated?

Ethical Drugs Private Limited was incorporated on 13 September 1978.

Who are the current directors of Ethical Drugs Private Limited?

The current directors of Ethical Drugs Private Limited are

What is the primary industry of Ethical Drugs Private Limited?

The primary industry of Ethical Drugs Private Limited is Chemicals.

Is Ethical Drugs Private Limited a listed company?

Ethical Drugs Private Limited is unlisted.

What is the capital structure of Ethical Drugs Private Limited?

The authorized capital of Ethical Drugs Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available